Board recommends Final Dividend

| Updated on May 28, 2018 Published on May 28, 2018

Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2018, inter alia, has recommended the Final Dividend of Re. 0.05/- per equity share (5% on the face value of Re. 1/- per equity share) for the financial year 2017-18, subject to the approval of Members at their Annual General Meeting.

Pdf Link: Board recommends Final Dividend

Source : BSE - www.bseindia.com

Published on May 28, 2018
This article is closed for comments.
Please Email the Editor